THE EFFECT OF COMBINATION THERAPY WITH GLICLAZIDE AND METFORMIN IN CONTROL OF BLOOD GLUCOSE OF TYPE 2 DIABETICS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

LANKARANI M.; BANDARIAN F.; TABATABAEI O.; PAZHOUHI M.; ARDESHIR LARIJANI MOHAMMAD BAGHER

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Diabetes and Metabolism Year:2004 | Volume:4 | Issue:1 Page(s): 59-64

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

102,952

Download:

Cites:

Information Journal Paper

Title

THE EFFECT OF COMBINATION THERAPY WITH GLICLAZIDE AND METFORMIN IN CONTROL OF BLOOD GLUCOSE OF TYPE 2 DIABETICS

Author(s)

Keywords

METFORMINQ4

GLICLAZIDEQ4

GLIBENCLAMIDEQ4

DIAMICRONQ4

DIABETES TYPE 2Q4

Abstract

Background: GLICLAZIDE is a second generation sulfonylurea which its efficacy and safety in the treatment of diabetes has been established. DIAMICRON MR (30 mg) is a new formulation of GLICLAZIDE with modified release which offer once daily dosage administration. This study was designed to assess the effect of combination therapy with DIAMICRON and METFORMIN in the treatment of type 2 diabetes.Methods: 16 patients with type 2 diabetes (2 males, 14 females) more than 35 years old who despite treatment with GLIBENCLAMIDE and METFORMIN had poor diabetes control participated in this clinical trial.HbA1c, lipid profile, liver and renal function tests at the end of study were compared with before.Results: No significant changes were found in FBS, BS2hpp, lipid profile and renal and liver function tests at the end of study. Patients' weight was stable during the study.Conclusion: Regardless of well efficacy of DIAMICRON in the treatment of new diabetics cases, it is not recommended for patients with poor diabetes control despite of combination therapy with METFORMIN and GLIBENCLAMIDE.

Cites

No record.

References

Cite

APA: Copy

LANKARANI, M., BANDARIAN, F., TABATABAEI, O., PAZHOUHI, M., & ARDESHIR LARIJANI, MOHAMMAD BAGHER. (2004). THE EFFECT OF COMBINATION THERAPY WITH GLICLAZIDE AND METFORMIN IN CONTROL OF BLOOD GLUCOSE OF TYPE 2 DIABETICS. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 4(1), 59-64. SID. https://sid.ir/paper/53967/en

Vancouver: Copy

LANKARANI M., BANDARIAN F., TABATABAEI O., PAZHOUHI M., ARDESHIR LARIJANI MOHAMMAD BAGHER. THE EFFECT OF COMBINATION THERAPY WITH GLICLAZIDE AND METFORMIN IN CONTROL OF BLOOD GLUCOSE OF TYPE 2 DIABETICS. JOURNAL OF DIABETES AND METABOLIC DISORDERS[Internet]. 2004;4(1):59-64. Available from: https://sid.ir/paper/53967/en

IEEE: Copy

M. LANKARANI, F. BANDARIAN, O. TABATABAEI, M. PAZHOUHI, and MOHAMMAD BAGHER ARDESHIR LARIJANI, “THE EFFECT OF COMBINATION THERAPY WITH GLICLAZIDE AND METFORMIN IN CONTROL OF BLOOD GLUCOSE OF TYPE 2 DIABETICS,” JOURNAL OF DIABETES AND METABOLIC DISORDERS, vol. 4, no. 1, pp. 59–64, 2004, [Online]. Available: https://sid.ir/paper/53967/en

Related Journal Papers